The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers
Drug Development Research · 2024
DOI: 10.1002/ddr.70014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, 2024. Verfasst von Ruixi Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Provincial Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, Clinical Cancer Research Center of…. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Fatty Acids, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 179 Literaturangaben. Gefördert von: This work was supported by National Natural Science Foundation of China (No. 32170791, 81972331, 81902998), Guozhong Health Group Science and Technology Projec….
Abstract (Originalsprache)
Gastrointestinal cancer has emerged as a significant global health concern due to its high incidence and mortality, limited effectiveness of early detection, suboptimal treatment outcomes, and poor prognosis. Metabolic reprogramming is a prominent feature of cancer, and fatty acid metabolism assumes a pivotal role in bridging glucose metabolism and lipid metabolism. Fatty acids play important roles in cellular structural composition, energy supply, signal transduction, and other lipid‐related processes. Changes in the levels of fatty acid metabolite may indicate the malignant transformation of gastrointestinal cells, which have an impact on the prognosis of patients and can be used as a marker to monitor the efficacy of anticancer therapy. Therefore, targeting key enzymes involved in fatty acid metabolism, either as monotherapy or in combination with other agents, is a promising strategy for anticancer treatment. This article reviews the potential mechanisms of fatty acid metabolism disorders in the occurrence and development of gastrointestinal tumors, and summarizes the related potential biomarkers and anticancer strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Provincial Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, Clinical Cancer Research Center of Shenyang, The First Hospital of China Medical University, Shenyang, L…
- Department of Oncology, Shanghai Electric Power Hospital, Shanghai, China.
ORCID-Profile: Chunlei Zheng
Förderung
- This work was supported by National Natural Science Foundation of China (No. 32170791, 81972331, 81902998), Guozhong Health Group Science and Technology Projec…
Zitieren
APA
Xie, R., Luo, Y., Bao, B., Wu, X., Guo, J., Wang, J., Qu, X., Che, X., & Zheng, C. (2024). The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers. Drug Development Research. https://doi.org/10.1002/ddr.70014
Vancouver
Xie R, Luo Y, Bao B, Wu X, Guo J, Wang J, et al. The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers. Drug Development Research. 2024. doi:10.1002/ddr.70014
BibTeX
@article{Xie2024,
author = {Xie, Ruixi and Luo, Ying and Bao, Bowen and Wu, Xinshu and Guo, Jia and Wang, Jin and Qu, Xiujuan and Che, Xiaofang and Zheng, Chunlei},
title = {The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers},
journal = {Drug Development Research},
year = {2024},
doi = {10.1002/ddr.70014}
}
EUVIMED